HGSC (N=89)	Non_HGSC (N=10)	P-value
Age (years)
Mean (SD)	56.1 (9.97)	46.8 (8.75)	0.115
Median [Min, Max]	56.0 [24.0, 82.0]	48.5 [30.0, 59.0]
Operation_history
Direct_surgery	56 (62.9%)	10 (100%)	0.062
Septal_tumor_reduction	1 (1.1%)	0 (0%)
Surgery_after_neoadjuvant	32 (36.0%)	0 (0%)
Type
CCC	0 (0%)	2 (20.0%)	<0.001
EC	0 (0%)	3 (30.0%)
HGSC	89 (100%)	0 (0%)
LGSC	0 (0%)	2 (20.0%)
MC	0 (0%)	2 (20.0%)
Missing	0 (0%)	1 (10.0%)
Clinical_stage
I	0 (0%)	1 (10.0%)	0.00925
II	6 (6.7%)	2 (20.0%)
III	42 (47.2%)	3 (30.0%)
IV	41 (46.1%)	4 (40.0%)
TMB_group
High	3 (3.4%)	2 (20.0%)	0.137
Low	84 (94.4%)	8 (80.0%)
Missing	2 (2.2%)	0 (0%)
Planting_metastasis
No	5 (5.6%)	2 (20.0%)	0.302
Yes	84 (94.4%)	8 (80.0%)
Lymph.node_metastasis
No	36 (40.4%)	5 (50.0%)	0.808
Yes	53 (59.6%)	5 (50.0%)
Relapse_within_6months
Yes	12 (13.5%)	1 (10.0%)	0.924
No	57 (64.0%)	7 (70.0%)
Unknown	20 (22.5%)	2 (20.0%)